STXS
Price
$0.99
Change
-$0.00 (-0.00%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
99.69M
19 days until earnings call
Intraday BUY SELL Signals
TWST
Price
$135.47
Change
-$13.66 (-9.16%)
Updated
Oct 22 closing price
Capitalization
8.98B
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

STXS vs TWST

STXS vs TWST Comparison Chart in %
View a ticker or compare two or three
VS
STXS vs. TWST commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STXS is a Hold and TWST is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for STXS with price predictions
Oct 22, 2026

STXS in downward trend: price dove below 50-day moving average on September 23, 2026

STXS moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend. In 28 of 31 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STXS as a result. In 86 of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for STXS turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 44 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STXS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for STXS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. STXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.143) is normal, around the industry mean (4.961). P/E Ratio (-4.145) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (12.600) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for TWST with price predictions
Oct 22, 2026

TWST sees MACD Histogram crosses below signal line

TWST saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 07, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 41 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for TWST moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In 37 of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.

The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TWST as a result. In 64 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

TWST moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TWST crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TWST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

TWST broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 63 cases where TWST's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

Following a +6.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where TWST advanced for three days, in 235 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 188 of 228 cases where TWST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.150) is normal, around the industry mean (2.973). TWST has a moderately low P/E Ratio (-60.749) as compared to the industry average of (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (20.243) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. TWST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 86 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TWST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
STXS vs TWST: Fundamental Ratings
STXS
TWST
OUTLOOK RATING
1..100
6471
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
8834
P/E GROWTH RATING
1..100
1591
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (4) in the Biotechnology industry is significantly better than the same rating for STXS (96) in the Medical Specialties industry. This means that TWST’s stock grew significantly faster than STXS’s over the last 12 months.

TWST's Profit vs Risk Rating (86) in the Biotechnology industry is in the same range as STXS (100) in the Medical Specialties industry. This means that TWST’s stock grew similarly to STXS’s over the last 12 months.

TWST's SMR Rating (97) in the Biotechnology industry is in the same range as STXS (100) in the Medical Specialties industry. This means that TWST’s stock grew similarly to STXS’s over the last 12 months.

TWST's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for STXS (88) in the Medical Specialties industry. This means that TWST’s stock grew somewhat faster than STXS’s over the last 12 months.

STXS's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for TWST (91) in the Biotechnology industry. This means that STXS’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STXSTWST
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (STXS: $0.99 vs. TWST: $135.47)
Brand notoriety: STXS and TWST are both not notable
STXS represents the Pharmaceuticals: Other, while TWST is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: STXS: 111% vs. TWST: 118%
Market capitalization -- STXS: $99.69M vs. TWST: $8.98B
STXS [@Pharmaceuticals: Other] is valued at $99.69M. TWST’s [@Biotechnology] market capitalization is $8.98B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STXS’s FA Score shows that 1 FA rating(s) are green while TWST’s FA Score has 1 green FA rating(s).

  • STXS’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 1 green, 4 red.
According to our system of comparison, TWST is a better buy in the long-term than STXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STXS’s TA Score shows that 3 TA indicator(s) are bullish while TWST’s TA Score has 3 bullish TA indicator(s).

  • STXS’s TA Score: 3 bullish, 5 bearish.
  • TWST’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, STXS is a better buy in the short-term than TWST.

Price Growth

STXS (@Pharmaceuticals: Other) experienced а -5.25% price change this week, while TWST (@Biotechnology) price change was -6.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.

Reported Earning Dates

STXS is expected to report earnings on Nov 10, 2026.

TWST is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Biotechnology (-1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
STXS
Daily Signal:
Gain/Loss:
TWST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+0.31%
SMTI - STXS
38%
Loosely correlated
+0.34%
TWST - STXS
36%
Loosely correlated
-9.16%
CERS - STXS
35%
Loosely correlated
-3.35%
VCYT - STXS
33%
Poorly correlated
-0.39%
SHC - STXS
32%
Poorly correlated
+2.03%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
INKM33.860.20
+0.61%
State Street Income Allocation ETF (INKM)
NBCE34.37N/A
N/A
Neuberger China Equity ETF (NBCE)
PFEB44.22-0.19
-0.43%
Innovator U.S. Equity Power Buffer ETF - February (PFEB)
EFV79.06-0.36
-0.45%
iShares MSCI EAFE Value ETF (EFV)
FCTE29.54-0.20
-0.68%
SMI 3Fourteen Full-Cycle Trend ETF (FCTE)